10058-F4 Catalog No.:M8326-2 14bS)-11-carboxy-4

14bS)-11-carboxy-4

the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

bolus 30 min after reperfusion developed smaller infarcts vs

Ki8751 (5 mg/kg) completely inhibits tumor growth without affecting body weight

10058-F4 Catalog No.:M8326-2 14bS)-11-carboxy-410058 F4 is a potent and selective c Myc inhibitor, which markedly increases valproic acid induced cell death in Jurkat and CCRF CEM T lymphoblastic leukemia cells. 10058 F4 inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. 10058 F4 induces cell cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Product information CAS